Mich. Comp. Laws § 333.26302

Current through Public Act 171 of the 2024 Legislative Session

Section 333.26302 - Notice; form; contents; size; modifications; locations

(1) An athletic services provider shall place the following notice in a form prescribed by the department in each educational athletic facility or recreational athletic facility owned or operated by that athletic services provider:

"WARNING!

USE:

A person who knowingly uses an androgenic anabolic steroid in violation of section 17766a of the public health code, Act No. 368 of the Public Acts of 1978, being section 17766a of the Michigan Compiled Laws is guilty of a misdemeanor, punishable by imprisonment for not more than 90 days, or a fine of not more than $100.00, or both.

POSSESSION:

A person who knowingly possesses an androgenic anabolic steroid in violation of section 17766a of Act No. 368 of the Public Acts of 1978 is guilty of a misdemeanor punishable by imprisonment for not more than 90 days, or a fine of not more than $100.00, or both. A second or subsequent violation is a felony, punishable by imprisonment for not more than 4 years, or a fine of not more than $2,000.00, or both.

DELIVERY:

A person who knowingly delivers or knowingly possesses with intent to deliver an androgenic anabolic steroid or counterfeit androgenic anabolic steroid to another person in violation of section 17766a of Act No. 368 of the Public Acts of 1978 is guilty of a felony, punishable by imprisonment for not more than 7 years, or a fine of not more than $5,000.00, or both.

POTENTIAL SIDE EFFECTS FROM USE:
Atrophy of the testicles	Enlarged breasts
Sterility	Impotence
Acne	Hair loss
Stroke	Kidney damage
Psychosis	Cardiovascular disease
Addiction	High blood pressure
Withdrawal	High blood cholesterol
Heart attack	Stunted bone growth
TRANSMITTED DISEASES AND INFECTIONS:

The shared use of hypodermic needles can result in the transmission of serious communicable diseases and infections including AIDS and hepatitis B.".

(2) The notice required under subsection (1) shall be not less than 8-1/2 inches by 11-1/2 inches. The information required to be printed on the notice shall be printed in 10-point boldfaced type or larger.

(3) The department may modify the contents of the notice required under subsection (1) to reflect changes in criminal penalties, scientific discoveries regarding the potential side effects from the use of androgenic anabolic steroids, and scientific evidence regarding serious communicable diseases and infections that may be transmitted by the shared use of hypodermic needles.

(4) An athletic services provider shall conspicuously place the notice required under subsection (1) in the following locations:

(a) If the facility is an educational athletic facility, in each locker room of that facility.

(b) If the facility is a recreational athletic facility, near each entrance and in each locker room of that facility.

MCL 333.26302

1990, Act 31, Eff. 6/27/1991.